corporate

Lessons from the Top 100: Boston Scientific [Podcast]

In this episode of Ideas to Innovation, we welcome David Knapp of Boston Scientific, one of the world’s Top 100 Global Innovators. Listen to the podcast now. Every year since 2012, Clarivate identifies the Top 100 Global Innovators. These are companies and institutions at the pinnacle of the global innovation landscape. They contributed new ideas, […]

Journal Citation Reports 2021: The evolution of journal intelligence [Podcast]

 In the Ideas to Innovation podcast series, we engage experts and industry leaders to discuss innovation at its core. Learn more about our podcast program.    For almost 50 years, the global research community has relied on the data in the Journal Citation Reports™ (JCR) to identify the world’s leading journals. The JCR is based on data from the Web […]

Drugs to Watch: Innovation in Alzheimer’s disease research [Podcast]

Welcome to the ‘Ideas to Innovation’ podcast series. In this new series, we engage in conversation with experts and industry leaders to discuss innovation at its core. Learn more about the new series. On June 7th, the U.S. Food and Drug Administration approved aducanumab, the first new Alzheimer’s treatment since 2003. Aducanumab is a monoclonal antibody […]

Introducing the ‘Ideas to Innovation’ podcast series from Clarivate

Introducing the ‘Ideas to Innovation’ podcast series from Clarivate, a global leader in providing solutions to accelerate the lifecycle of innovation, helping customers solve some of the world’s most complex problems. Join conversations with experts and industry leaders to discuss innovation at its core, from science and research to intellectual property and beyond.  

Gaining insight with artificial intelligence

In part three of this blog series about best practices in toxicology, we continue the discussion from previous articles that outlined elements in the discovery stage that could impact safety, and considering a drug’s effects on toxicity of specific organs and specific patients via toxicogenomics, pharmacogenomics and pharmacoepigenomics. To help reach a deeper understanding of […]

The Clarivate story continues

Did you know that the name Clarivate is derived from the three words clarity, activate and innovate? That’s because we give our customers the clarity they need in order to activate a lifecycle of innovation. Innovation doesn’t just happen – it’s a process. Every invention we use, product we buy and service we consume has […]